David Shaw’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

David Shaw’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-56,883	Closed	-$136K	–	4709
2023 Q3	$136K	Sell	56,883 -56,365	-50%	-$125K	﹤0.01%	3823
2023 Q2	$262K	Sell	113,248 -93,859	-45%	-$265K	﹤0.01%	3647
2023 Q1	$528K	Sell	207,107 -184,334	-47%	-$528K	﹤0.01%	3525
2022 Q4	$983K	Sell	391,441 -88,766	-18%	-$248K	﹤0.01%	3463
2022 Q3	$1.39M	Buy	480,207 +173,022	+56%	+$728K	﹤0.01%	3330
2022 Q2	$1.39M	Buy	307,185 +192,534	+168%	+$1.15M	﹤0.01%	3391
2022 Q1	$920K	Sell	114,651 -165,375	-59%	-$1.46M	﹤0.01%	3981
2021 Q4	$3.26M	Sell	280,026 -1,052,336	-79%	-$12.6M	﹤0.01%	2859
2021 Q3	$16.5M	Buy	+1,332,362	New	+$15M	0.01%	1147

Other funds holding SLGC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David Shaw's SLGC Position: Q4 2023 in Review

David Shaw sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q4 2023, closing a stake of 56,883 shares — an estimated $136K sold.

David Shaw first reported a position in SLGC in Q3 2021 and held it in 9 quarters. The position peaked at $16.5M in Q3 2021. 119 funds tracked by Wall St. Rank hold SLGC as of Q4 2023.

David Shaw reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
David Shaw sold 56,883 SomaLogic, Inc. Class A Common Stock shares in Q4 2023, an estimated $136K.
David Shaw first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 9 quarters.
David Shaw's SomaLogic, Inc. Class A Common Stock position peaked at $16.5M in Q3 2021.
119 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.